跳至主要内容
临床试验/ACTRN12615000901505
ACTRN12615000901505已完成2 期

A double blind randomized controlled study to evaluate the efficacy of different doses of oral Channa striatus extract versus Glucosamine Sulphate among knee osteoarthritis patients

niversiti Sains Malaysia0 个研究点目标入组 156 人开始时间: 2015年8月27日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
156

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
40 Years 至 o limit(—)
性别
All

入选标准

  • 1-All patients with unilateral or bilateral knee osteoarthritis according to clinical and radiological criteria of the American College of Rheumatology (ACR) (Altman et al. 1986)
  • Knee pain and radiographic osteophytes plus at least one of three symptoms/signs listed below:
  • -age more than 40 years OR
  • -stiffness less than 30 minutes OR
  • -crepitus.
  • This criteria is widely accepted as the standard diagnosis criteria for knee OA with 91% sensitivity and 86% specificity.
  • 2-Have a radiological grade between I and III, as measured with the Kellgren-Lawrence method of Classification.
  • 3-Patients have symptoms for at least three months.

排除标准

  • 1-Patient with secondary knee osteoarthritis, such as post traumatic OA, inflammatory arthritis, specifically rheumatoid arthritis, active gout
  • 2-Disabling co-morbid condition such as renal disease, liver disease, neoplasm, and other rheumatic diseases.
  • 3-Pregnancy or nursing.
  • 4-Patient with severe knee pain and willing for surgical intervention.
  • 5-Those who had joint lavage, arthroscopy, or treatment with hyaluronic acid during the previous 6 months.
  • 6-Patient who had been treated with intra-articular corticosteroids during the past 3 months.
  • 7-Patient who have allergic to oral C.striatus or Glucosamine

研究者

发起方
niversiti Sains Malaysia

相似试验